New leveraged cannabis ETF hits the market, doubling the returns of MSOS

CBD Beautiful background green cannabis flowers.Cannabis Sativa Leaves On Dark - Medical Legal Marijuana.cbd oil - medical marijuana concept,alternative herb medicine.

IURII BUKHTA

Cannabis investors now have access to a new 2X leveraged ETF by AdvisorShares. The AdvisorShares MSOS 2x Daily ETF (NYSEARCA:MSOX) is a new fund that provides two times the daily performance of the popular AdvisorShares Pure US Cannabis ETF (NYSEARCA:MSOS).

The underlying MSOS is an actively managed U.S.-listed ETF with cannabis exposure that exclusively applies to U.S. companies, including multi-state operators.

MSOX provides the investment community with increased buying power as it delivers 2X the cannabis exposure in a single trade, which gives holders of MSOX overweight cannabis holdings for less cash.

Additionally, MSOX will be attached with a total operating expense ratio of 0.95%, higher than the 0.73% expense ratio that is tagged to MSOS.

Dan Ahrens, portfolio manager of both MSOX and MSOS stated: “We believe MSOX is a unique investment tool that is designed specifically for experienced investors and professional traders which can potentially provide amplified returns in all market environments."

On Wednesday MSOS is +2.7% but from a larger year-to-date vantage point, MSOS is -54.8%.

Other related cannabis ETFs: (MJ), (YOLO), (POTX), (CNBS), (THCX), and (TOKE).

See additional information about the launch of the AdvisorShares MSOX.

Recommended For You

Comments (13)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.